Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1617 | 0.6329 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0054 | 0.0164 |
Schistosoma mansoni | single-minded | 0.01 | 0.0487 | 0.1908 |
Brugia malayi | hypoxia-induced factor 1 | 0.031 | 0.2761 | 0.8414 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0358 | 0.3281 | 0.3281 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1617 | 0.1617 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.01 | 0.0487 | 0.1908 |
Brugia malayi | bZIP transcription factor family protein | 0.0358 | 0.3281 | 1 |
Onchocerca volvulus | 0.0281 | 0.2448 | 1 | |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0358 | 0.3281 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1617 | 0.6329 |
Loa Loa (eye worm) | hypothetical protein | 0.0349 | 0.3175 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.1617 | 0.4927 |
Loa Loa (eye worm) | hypothetical protein | 0.0336 | 0.3043 | 0.9584 |
Brugia malayi | hypothetical protein | 0.0281 | 0.2448 | 0.7461 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0054 | 0.0169 |
Brugia malayi | hypothetical protein | 0.0336 | 0.3043 | 0.9273 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0054 | 0.0164 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.031 | 0.2761 | 0.8695 |
Brugia malayi | bHLH-PAS transcription factor | 0.0074 | 0.0205 | 0.0626 |
Echinococcus granulosus | single minded 2 | 0.0074 | 0.0205 | 0.0626 |
Brugia malayi | PAS domain containing protein | 0.01 | 0.0487 | 0.1485 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.2408 | 0.5 |
Echinococcus multilocularis | jun protein | 0.0358 | 0.3281 | 0.3281 |
Echinococcus granulosus | jun protein | 0.0358 | 0.3281 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0054 | 0.0169 |
Schistosoma mansoni | jun-related protein | 0.0291 | 0.2555 | 1 |
Echinococcus multilocularis | transfer RNA-Lys | 0.0074 | 0.0205 | 0.0205 |
Mycobacterium ulcerans | putative regulatory protein | 0.0074 | 0.0205 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0291 | 0.2555 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.